PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
10965884-0	2000	The peroxisome proliferator perfluorodecanoic acid inhibits the peripheral-type benzodiazepine receptor (PBR) expression and hormone-stimulated mitochondrial cholesterol transport and steroid formation in Leydig cells.	perfluorodecanoic acid	28-50	translocator protein	Mus musculus	64-103	
10965884-0	2000	The peroxisome proliferator perfluorodecanoic acid inhibits the peripheral-type benzodiazepine receptor (PBR) expression and hormone-stimulated mitochondrial cholesterol transport and steroid formation in Leydig cells.	perfluorodecanoic acid	28-50	translocator protein	Mus musculus	105-108	
10965884-11	2000	Further studies indicated that PFDA did not affect PBR transcription, but it rather accelerated PBR mRNA decay.	perfluorodecanoic acid	31-35	translocator protein	Mus musculus	96-99	
10965884-12	2000	Taken together, these data suggest that PFDA inhibits the Leydig cell steroidogenesis by affecting PBR mRNA stability, thus inhibiting PBR expression, cholesterol transport into the mitochondria, and the subsequent steroid formation.	perfluorodecanoic acid	40-44	translocator protein	Mus musculus	99-102	
10965884-12	2000	Taken together, these data suggest that PFDA inhibits the Leydig cell steroidogenesis by affecting PBR mRNA stability, thus inhibiting PBR expression, cholesterol transport into the mitochondria, and the subsequent steroid formation.	perfluorodecanoic acid	40-44	translocator protein	Mus musculus	135-138	
10965884-13	2000	Moreover, this action of PFDA on PBR mRNA stability indicates a new mechanism of action of peroxisome proliferators distinct from the classic transcription-mediated regulation of target genes.	perfluorodecanoic acid	25-29	translocator protein	Mus musculus	33-36